†Based on internal analyses of acquisition, service and operating costs. Not intended to compare clinical outcomes among robotic surgery systems.
The Hugo™ RAS system is commercially available in certain geographies. Regulatory requirements of individual countries and regions will determine approval, clearance, or market availability. In Canada, the Hugo™ RAS system has a Health Canada licence. In the EU, the Hugo™ RAS system is CE marked. In the U.S., the Hugo™ RAS system is an investigational device not for sale. Touch Surgery Enterprise is not intended to direct surgery, or aid in diagnosis or treatment of a disease or condition.